Guardian P Global Qualit... Stock Quote GIQG - Stock Price, News, Charts, Message Board, Trades

Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
ETFs
Canada
TSX
Guardian P Global Quality Growth ETF (GIQG) Quote

Guardian P Global Quality Growth ETF (GIQG)

30.05

-0.32

(-1.05%)

Closed January 13 4:12PM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

30.05

Bid

29.94

Ask

30.15

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

30.37

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

250,000

Dividend Yield

-

PE Ratio

3.34

Earnings Per Share (EPS)

9.1

Revenue

2.38M

Net Profit

2.28M

Sector

Finance Services

Industry

Finance Services

Headquarters

Toronto, Ontario, Can

Founded

-

Guardian P Global Quality Growth ETF is listed in the Finance Services sector of the Toronto Stock Exchange with ticker GIQG. The last closing price for Guardian P Global Qualit... was $30.37. Over the last year, Guardian P Global Qualit... shares have traded in a share price range of $ 0.00 to $ 0.00.

Guardian P Global Qualit... currently has 250,000 shares outstanding. The market capitalization of Guardian P Global Qualit... is $7.59 million. Guardian P Global Qualit... has a price to earnings ratio (PE ratio) of 3.34.

Guardian Capital Confirms Annual 2024 Special Distributions for Guardian Capital ETFs

TORONTO, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Guardian Capital LP ("Guardian Capital") announces the confirmed amounts of the annual special year-end distributions (the "Special Distributions") for...

Guardian Capital Announces December 2024 Cash Distributions for Guardian Capital ETFs

TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending December 31, 2024, in respect of the ETF series of the...

Guardian Capital Announces Estimated Annual 2024 Special Distributions for Guardian Capital ETFs

TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Guardian Capital LP ("Guardian Capital") announces the estimated annual special year-end distributions (the "Special Distributions") for the 2024 tax...

Guardian Capital Announces September 2024 Cash Distributions for Guardian Capital ETFs

TORONTO, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending September 30, 2024, in respect of the ETF series of the...

Guardian Capital Announces June 2024 Cash Distributions for Guardian Capital ETFs

TORONTO, June 14, 2024 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending June 30, 2024, in respect of the ETF series of the...

Guardian Capital Announces March 2024 Cash Distributions for Guardian Capital ETFs

TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending March 31, 2024, in respect of the ETF series of the...

Guardian Capital Announces June 2023 Distributions for Guardian Capital ETFs

TORONTO, June 16, 2023 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending June 30, 2023, in respect of the ETF series of the...

Guardian Capital Announces March 2023 Distributions for Guardian Capital ETFs

TORONTO, March 17, 2023 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending March 31, 2023, in respect of the ETF series of the...

Guardian Capital Confirms Annual 2022 Special Distributions for Guardian Capital ETFs

TORONTO, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Guardian Capital LP ("Guardian Capital") announces the confirmed amounts of the annual special year-end distributions (the "Special Distributions") for...

Guardian Capital Announces December 2022 Distributions for Guardian Capital ETFs

TORONTO, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending December 31, 2022, in respect of the ETF series of the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VRMEVerifyMe Inc	$ 2.57 (52.98%)	57.83M
WKEYWISeKey International Holdings AG	$ 10.041 (52.83%)	6.72M
DATSDatChat Inc	$ 4.8105 (49.86%)	158.65M
CDTConduit Pharmaceuticals Inc	$ 0.1214 (48.05%)	1.17B
INTZIntrusion Inc	$ 2.8888 (44.44%)	40.61M
IGMSIGM Biosciences Inc	$ 2.095 (-66.21%)	5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd	$ 1.87 (-51.30%)	2.28M
MODVModivCare Inc	$ 6.51 (-47.88%)	2.73M
AIFUAIX Inc	$ 0.420501 (-47.76%)	7.85M
MRSNMersana Therapeutics Inc	$ 0.691 (-46.85%)	58.44M
CDTConduit Pharmaceuticals Inc	$ 0.1214 (48.05%)	1.17B
NVDANVIDIA Corporation	$ 135.91 (-3.00%)	207.53M
RGTIRigetti Computing Inc	$ 8.9299 (-11.06%)	178.82M
VMARVision Marine Technologies Inc	$ 2.14 (40.79%)	175.57M
DATSDatChat Inc	$ 4.8105 (49.86%)	158.65M

gfp927z

gfp927z 9 minutes ago

>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall

gfp927z

gfp927z 10 minutes ago

>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall

georgebailey

georgebailey 10 minutes ago

Steady I think the rubber hits the road when we see the MHRA label assignment on L. Based on safety, phase 3 and RWE we just might see a broad scope label which I’ll call a home run.

Birdbrain Ideas

Birdbrain Ideas 11 minutes ago

If what you suggest is a possibility, I would view the early December "Investor's Day" in hindsight as more of a dog and pony show for potential buyers. At this point, investors have been beaten to the point that most of us would accept if the company was sold for $6 or $7 a share. What would that b

devil dog 96

devil dog 96 13 minutes ago

In October of 2023 The best setup in the OTC challenge was posted and ATMH still holds the #1 spot! Not one ticker has been found with a better setup! 🏆️

If anyone wants to take the challenge and prove me wrong here is the link https://investorshub.advfn.com/b

3jack

3jack 13 minutes ago

We know who you are!

gfp927z

gfp927z 14 minutes ago

>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari

3jack

3jack 14 minutes ago

We know who you are!

gfp927z

gfp927z 14 minutes ago

>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari

Lazerator

Lazerator 17 minutes ago

Not "walking dead", just dead. I just wish they'd declare bankruptcy instead of pretending like it's going to trade again.

Lazerator

Lazerator 18 minutes ago

Clearly, Port turned out to be the fool. Actually, he made fools of all you guys who bought into his scam.

imho

imho 19 minutes ago

In the comment section of this article,
https://seekingalpha.com/article/4748984-playing-the-odds-of-anavex-alzheimers-drug-approval#scroll_comments

Someone named Stephen Ayers in his Saturday, 12:42PM comment, says

I asked ChatGPT why the following statement, w

Ryoko

Ryoko 19 minutes ago

It's not going to be audited. They lied again. They do that once a year. Been that way for the last 4 years.

axelvento

axelvento 22 minutes ago

has announced that it will be paying its dividend of $0.43 on the 7th of March, an increased payment from last year's comparable dividend. This makes the dividend yield 6.5%, which is above the industry average

$PFE

Steady_T

Steady_T 25 minutes ago

You might be correct about the size of the GBM market in the UK. However you are missing the point.

Approval in the UK validates the MOA and the potential of treating other solid cancers. That will have much more impact than the limited size of the UK market.

Approval

skitahoe

skitahoe 25 minutes ago

While I'd love you to be right, that would represent over a $14 billion market cap, I believe that's high until the EDEN is available for production of the vaccine. I just don't believe that enough vaccine can be produced in Sawston to justify that market cap until they can make more, which require

Saving Grace

Saving Grace 25 minutes ago

Putz: We are not at 2 years. Who's we? LoL SMH

Keep an eye on the door. Big revelation! It's coming. UK

elks

elks 26 minutes ago

commdude

commdude 26 minutes ago

I purchased some MJLink stocks a few years ago via their web portal. I assume they are pretty much worthless now, or????

It wasn't a large investment, and just crossed my mind that I have them after revisiting this forum.

TradingCharts

TradingCharts 28 minutes ago

Page 2 Signed July 26, 2024

https://cases.stretto.com/public/X063/10210/PLEADINGS/1021007262480000000235.pdf
7. Stalking Horse. The Trustee has demonstrated a sound business justification for
the Court to approve (i) Meteor Energy, LLC or its designee as the Stalking

Steady_T

Steady_T 31 minutes ago

Good article with a positive slant. It did touch on the potential negatives to give some balance.

Hopefully that is enough depth to generate some interest in Anavex. He did make clear that the approval is likely to be late in the year.

At this point I see a lot of vola

axelvento

axelvento 32 minutes ago

Why Is There No Vaccine For Norovirus As It Spreads Across US? How Much Do You Need To Wait ?
Among the most promising is the vaccine candidate from Moderna—currently being tested in human participants, says Health.com

https://www.timesnownews.com/health/why-is-there-no-vaccine

Oleblue

Oleblue 32 minutes ago

D-Wave Announces 2024 Bookings and First On-Premise Advantage System Sale

Capital Markets, Quantum Computing Business

Cierra Choucair
January 10, 2025

D-Wave Quantum Inc. reported fiscal year 2024 bookings exceeding $23 million, a

fuagf

fuagf 33 minutes ago

You have to be right, when it comes to money and power Musk has everything Trump wants. Wondering what Bannon could have up his sleeve, going out on a limb about keeping Musk out of the White House as he did. Just fell asleep for some two hours. Good break, but always feel lousy after.

Guardian P Global Qualit...

Delayed Upgrade Clock